Enbrel and Irritable bowel syndrome - a phase IV clinical study of FDA data
Summary:
Irritable bowel syndrome is found among people who take Enbrel, especially for people who are female, 40-49 old, have been taking the drug for 6 - 12 months.
The phase IV clinical study analyzes which people take Enbrel and have Irritable bowel syndrome. It is created by eHealthMe based on reports of 633,316 people who have side effects when taking Enbrel from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
633,316 people reported to have side effects when taking Enbrel.
Among them, 2,492 people (0.39%) have Irritable bowel syndrome.
What is Enbrel?
Enbrel has active ingredients of etanercept. It is often used in rheumatoid arthritis. eHealthMe is studying from 635,061 Enbrel users for its effectiveness, alternative drugs and more.
What is Irritable bowel syndrome?
Irritable bowel syndrome is found to be associated with 2,652 drugs and 2,067 conditions by eHealthMe.
Number of Enbrel and Irritable bowel syndrome reports submitted per year:

Time on Enbrel when people have Irritable bowel syndrome *:
Gender of people who have Irritable bowel syndrome when taking Enbrel*:
Age of people who have Irritable bowel syndrome when taking Enbrel *:
Common drugs people take besides Enbrel *:
Common side effects people have besides Irritable bowel syndrome *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Enbrel and have Irritable bowel syndrome?
Check whether Irritable bowel syndrome is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Irritable bowel syndrome and when was it recovered:
Expand to all the drugs that have ingredients of etanercept:
Alternative drugs to, pros and cons of Enbrel:
- Enbrel (635,061 reports)
Common Enbrel side effects:
- Drug ineffective: 90,931 reports
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints): 56,708 reports
- Joint pain: 49,616 reports
- Pain: 47,830 reports
- Fatigue (feeling of tiredness): 32,388 reports
- Rashes (redness): 29,304 reports
Browse all side effects of Enbrel:
a b c d e f g h i j k l m n o p q r s t u v w x y zIrritable bowel syndrome treatments and more:
- Irritable bowel syndrome (43,479 reports)
COVID vaccines that are related to Irritable bowel syndrome:
- Irritable bowel syndrome in Moderna COVID Vaccine
- Irritable bowel syndrome in Pfizer BioNTech Covid Vaccine
- Irritable bowel syndrome in Johnson and Johnson Covid Vaccine
Common drugs associated with Irritable bowel syndrome:
- Accutane: 4,848 reports
- Prednisone: 2,927 reports
- Methotrexate: 2,728 reports
- Enbrel: 2,492 reports
- Profen: 2,356 reports
- Ibu: 2,355 reports
- Ibuprofen: 2,355 reports
- Humira: 2,258 reports
- Cimzia: 2,159 reports
- Simponi: 2,131 reports
All the drugs that are associated with Irritable bowel syndrome:
- Irritable bowel syndrome (2,652 drugs)
Common conditions associated with Irritable bowel syndrome:
- Rheumatoid arthritis: 3,944 reports
- Acne: 3,224 reports
- High blood pressure: 1,869 reports
- Osteoporosis: 1,043 reports
- Pain: 876 reports
- Multiple sclerosis: 850 reports
All the conditions that are associated with Irritable bowel syndrome:
- Irritable bowel syndrome (2,067 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on etanercept (the active ingredients of Enbrel) and Enbrel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lorelco and Fainting - a second ago
- Duragesic-100 vs. Oxycodone 5/Apap 500 - 6 seconds ago
- Oxycodone 5/Apap 500 vs. Carisoprodol - 11 seconds ago
- Methocarbamol vs. Oxycodone 5/Apap 500 - 14 seconds ago
- Tramadol vs. Zorvolex - 20 seconds ago
- Ultracet vs. Oxycodone 5/Apap 500 - 23 seconds ago
- Oxycodone 5/Apap 500 vs. Voltaren - 24 seconds ago
- Oxycodone 5/Apap 500 vs. Percodan - 24 seconds ago
- Bydureon and Gastric Ulcer - 28 seconds ago
- Lyrica vs. Oxycodone 5/Apap 500 - 30 seconds ago